Escalon Medical Corp (ESMC) stock
ESMCOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Oct 13, 2026Score 10/30
$0.18+0.01 (+7.65%)
Close on Oct 19, 2026Market cap $2.72MP/E 0.7Yield –
Escalon Medical total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Escalon Medical's total debt was $0 at Jun 30, 2023. For fiscal 2023 it was $0, down 100.0% from the year before. The highest annual figure on record is $4.78M in fiscal 2011.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Jun 30, 2023 | $0 | -100.0% |
| FY2022 | Jun 30, 2022 | $201.58K | 0.0% |
| FY2021 | Jun 30, 2021 | $201.58K | 0.0% |
| FY2020 | Jun 30, 2020 | $201.58K | 0.0% |
| FY2019 | Jun 30, 2019 | $201.58K | +22.2% |
| FY2018 | Jun 30, 2018 | $165.00K | -34.0% |
| FY2017 | Jun 30, 2017 | $250.00K | – |
| FY2016 | Jun 30, 2016 | $0 | – |
| FY2013 | Jun 30, 2013 | $0 | -100.0% |
| FY2012 | Jun 30, 2012 | $4.15M | -13.3% |
| FY2011 | Jun 30, 2011 | $4.78M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $0 | -100.0% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $201.58K | 0.0% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $201.58K | 0.0% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $201.58K | 0.0% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $201.58K | 0.0% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $201.58K | 0.0% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $201.58K | 0.0% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $201.58K | 0.0% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $201.58K | +22.2% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $201.58K | +969.2% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $201.58K | -68.7% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $201.58K | -19.4% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $165.00K | – |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $18.85K | – |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $645.00K | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $250.00K | – |
See a number that looks wrong?